24 Participants NeededMy employer runs this trial

AIC263029 for BK Virus Infection

Recruiting at 6 trial locations
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: AiCuris Anti-infective Cures AG
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to learn if AIC263029 is safe and well tolerated in adult kidney transplant recipients with BK virus (BKV) in the blood (viremia). The study will also examine how the body processes AIC263029 and whether it lowers BKV levels in the blood.

Researchers will compare AIC263029 to a placebo (a look-alike injection with no active drug). Participants will be assigned by chance to receive AIC263029 or placebo and will receive weekly injections under the skin for 4 weeks. Participants will have clinic visits and blood tests during treatment and follow-up to monitor safety and measure BKV levels, and will be followed for up to about 24 weeks after treatment.

Are You a Good Fit for This Trial?

This trial is for adults (18+) who have had a kidney transplant within the past year and currently have BK virus in their blood at certain levels. Participants must agree to use effective birth control, not donate sperm, test negative for pregnancy if female, and be able to give informed consent.

Inclusion Criteria

I agree not to donate sperm and will use protection or abstain during the trial.
I agree to use effective birth control or abstain from sex during the trial.
I had a kidney transplant within the past 12 months.
See 4 more

What Are the Treatments Tested in This Trial?

Interventions

  • AIC263029

Trial Overview

The study tests AIC263029 versus placebo in people with BK virus after kidney transplant. Participants are randomly assigned to get weekly under-the-skin injections of either AIC263029 or placebo for 4 weeks, with follow-up visits and blood tests over about 24 weeks.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: AIC263029Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

AiCuris Anti-infective Cures AG

Lead Sponsor

Trials
9
Recruited
2,000+